GNRHR and endometriosis: The phase 2 TERRA study, a double-blind, randomized, parallel-group, placebo-controlled clinical trial, used the EPDD to assess the efficacy of a GnRH receptor antagonist, ASP1707, in women with endometriosis-associated pelvic pain.